Navigation Links
Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008
Date:4/9/2008

energy and focus is reflected in several important initiatives. CETHRIN, a recombinant-protein-based drug designed to promote nerve repair after acute spinal cord injury, demonstrated positive interim results in a Phase I/IIa clinical trial. The Company's research and pre-clinical programs include, Inosine for the treatment of spinal cord injury and stroke, Oncomodulin for the treatment of ocular injury and disease and research programs directed at a number of regenerative therapies including bone repair. The Company has a robust molecular imaging development program targeting diagnosis of Parkinson's disease and potentially dementia and ADHD. The Company's lead molecular imaging product candidate is ALTROPANE which is in Phase III clinical trials for the diagnosis of Parkinsonian Syndromes including Parkinson's Disease. The Company has research collaborations with Harvard Medical School and Children's Hospital Boston.

Forward-Looking Statements

The foregoing release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward- looking statements include statements regarding Alseres Pharmaceuticals' future expectations, beliefs, intentions, goals, strategies, plans or prospects regarding the future, including the development and commercialization of ALTROPANE and CETHRIN, the prospects of the Company's CNS and regenerative therapeutics program, the Company's strategies to develop and commercialize axon regeneration technologies and the breadth of the Company's technologies and intellectual property portfolio. Forward-looking statements can be identified by terminology such as "anticipate," "believe," "could," "could increase the likelihood," "estimate," "expect," "intend," "is planned," "may," "should," "will," "will enable," "would be expected," "look forward," "may provide," "would" or similar terms, variations of such terms or the negative of those terms. Such forward-looking statem
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alseres Pharmaceuticals Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
2. Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
3. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
8. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
9. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
10. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
11. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 Object recognition technology ... visually impaired and elderly. The VelaSense ® ... to lead more independent, productive and fulfilling lives. VelaSense ... will allow users to identify objects from a one ... as create customized object databases for personal use. ...
(Date:3/27/2015)... WASHINGTON , March 27, 2015 ... - The biopharmaceutical industry comes out on top as ... in a new report  from ndp│analytics. According to ... and development (R&D) investment over the last decade, accounting ... 2000-2012. A Short Video on ...
(Date:3/27/2015)... Zimmer Holdings, Inc. (NYSE and SIX: ZMH) is celebrating a key milestone ... Complete Knee System. ,   ... first introduced the NexGen knee system, with its innovative design ... implantations of the NexGen knee have taken place worldwide. ... demonstrates the importance of design innovation and component quality for surgeons and ...
Breaking Medicine Technology:VelaSense Object Recognition Technology for the Blind was unveiled at Baruch College's CCVIP 8th Annual Conference 2Week in Review: The Latest from PhRMA 2Zimmer Celebrates Key Milestones For NexGen Complete Knee System 2
... Report from Trial of Quadramet in Combination with Velcade for ... 11 Quadramet (153 Samarium-lexidronam) is ... and is used to treat pain caused by cancer that ... (bortezomib) is approved for the treatment of ...
... 10 Endo Pharmaceuticals (Nasdaq: ENDP ) ... agreements to develop novel treatments for pain and to ... with Harvard University , is based upon a ... Harvard Medical School,s Richard J. Kitz Professor of Anaesthesia ...
Cached Medicine Technology:Phase 1 Trial of Quadramet in Combination with Velcade Shows Positive Results 2Endo Pharmaceuticals Announces Research Collaborations to Develop Novel Pain Treatments and Discover Potential Cancer Treatments 2Endo Pharmaceuticals Announces Research Collaborations to Develop Novel Pain Treatments and Discover Potential Cancer Treatments 3
(Date:3/29/2015)... 29, 2015 “Health is an endo ... we learn more about the cannabinoid system … we ... Homeostasis: Publius’ Go Endo-Cannabinoid Update ~ new on ... is celebrated. Publius, of The Cannabis Papers: A citizen’s ... of Health (PubMed) cannabinoid system (CS) articles discussing: cannabinoids ...
(Date:3/28/2015)... March 28, 2015 "Necrorun" was featured ... takes a look at the latest and coolest applications ... Troohey, the host of NewsWatch and technology expert, conducted ... is an entertaining endless runner game with knights, nature, ... was released in 2009, according to Eurogamer. The popularity ...
(Date:3/28/2015)... The California-based leading wig brand UniWigs has prepared ... UniWigs during the Easter Holidays from today until April ... April Fools’ Day. , As the winter fades and ... Easter Festival, with religious origins to countries in Europe ... Christmas. The best wig provider, UniWigs, would like to ...
(Date:3/28/2015)... Centurion Service Group will be hosting a live on-site and ... Las Vegas warehouse, located at 4606 Andrews St. Suite 3, ... equipment from hospitals and surgery centers from around the United ... Buyers will find items of all types including anesthesia, endoscopy, ... Erik Tivin, CEO of Centurion. , Among the sale’s ...
(Date:3/28/2015)... Delaying rotator cuff surgery on patients ... research presented today at the American Orthopaedic Society for ... study compared results for 170 patients who received rotator ... joint capsule release procedure to relieve stiffness at the ... author from St. George Hospital in Sydney, Australia. “Both ...
Breaking Medicine News(10 mins):Health News:March Homeostasis: Publius’ Go Endo-Cannabinoid Update ~ New on the Bryan William Brickner Blog 2Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2
... An international,organization dedicated to furthering the advancement ... (GSK) Consumer Healthcare executive today,during an awards ... Ernestine Harris,GSK Consumer Healthcare,s U.S. director of ... Star" by the Healthcare Businesswomen,s Association,(HBA). The ...
... time, a detailed map of how the building blocks of ... the fruit fly Drosophila melanogaster. The work identifies a ... expression, and has implications for understanding how the AIDS virus ... the 15 May 2008 issue of the journal Nature. , ...
... nation,can no longer afford the human and financial toll ... Senate Health, Education, Labor,and Pension (HELP) Committee that "we ... got. We,ve got to fight it with the strategy ... at a HELP Committee,hearing on cancer challenges and opportunities ...
... Project Anchor Phase I complete with secure transmission of patient ... from ... R.I., May 8 /PRNewswire/,--InterComponentWare Inc. (ICW), a global leader in ... yesterday,the completion of the first phase of Project Anchor, an ...
... Using gene therapy, plastic surgeons have delivered cancer fighting ... rats with a 79 percent reduction in tumor volume, ... Plastic and Reconstructive Surgery, the official medical journal of ... new delivery technique, which has yet to be tested ...
... REDWOOD CITY, Calif., May 8 Genomic Health,Inc. (Nasdaq: ... Genomic,Health,s Chairman and Chief Executive Officer, will present at ... NV on Wednesday, May 14,2008 at 3:20 p.m. Pacific ... and Chief Operating,Officer, will present at the 7th Annual ...
Cached Medicine News:Health News:GSK's Ernestine Harris Honored as Industry 'Rising Star' by Healthcare Businesswomen's Association 2Health News:GSK's Ernestine Harris Honored as Industry 'Rising Star' by Healthcare Businesswomen's Association 3Health News:Scientists identify key roadblock to gene expression 2Health News:FasterCures President Greg Simon Testifies to U.S. Senate HELP Committee on Cancer Challenges and Opportunities in the 21st Century 2Health News:InterComponentWare Inc. and Memorial Hospital of Rhode Island Celebrate Milestone 2Health News:InterComponentWare Inc. and Memorial Hospital of Rhode Island Celebrate Milestone 3Health News:InterComponentWare Inc. and Memorial Hospital of Rhode Island Celebrate Milestone 4Health News:Skin flaps deliver cancer-fighting therapy, ASPS study reveals 2Health News:Genomic Health to Present at Bank of America 2008 Healthcare Conference and 7th Annual JMP Securities Research Conference 2
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Medicine Products: